Equities
  • Price (USD)258.21
  • Today's Change0.00 / 0.00%
  • Shares traded58.00
  • 1 Year change+60.59%
  • Beta--
Data delayed at least 20 minutes, as of Sep 16 2021 19:12 BST.
More ▼
Take Survey
Help shape our future virtual events & community services
Take part in our survey for a chance to win a free 3-month standard gift subscription.

Profile data is unavailable for this security.

About the company

IQVIA Holdings Inc., formerly Quintiles IMS Holdings, Inc., provides integrated information and technology-enabled healthcare services. The Company operates through segments, including Commercial Solutions; Research & Development Solutions, and Integrated Engagement Services. The Commercial Solutions segment offerings include national information offerings, sub-national information offerings, technology solutions, and workflow analytics and consulting services. The Research & Development Solutions segment provides biopharmaceutical development services. It offers project management and clinical monitoring, clinical trial support services, Q2 solutions, and strategic planning and design. The Integrated Engagement Services segment offerings include healthcare provider engagement services, patient engagement services, and scientific strategy and medical affairs services. The Company has its operations in the Americas, Europe and Africa, and the Asia-Pacific.

  • Revenue in USD (TTM)12.93bn
  • Net income in USD607.00m
  • Incorporated2016
  • Employees72.00k
  • Location
    IQVIA Holdings Inc4820 Emperor BlvdDURHAM 27703-8426United StatesUSA
  • Phone+1 (919) 998-2000
  • Fax+1 (302) 636-5454
  • Websitehttps://ir.iqvia.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
IQV:NYQ since
announced
Transaction
value
Q Squared Solutions Holdings LLCDeal completed01 Apr 202101 Apr 2021Deal completed32.72%760.00m
Kairos GmbHDeal completed01 Mar 202101 Mar 2021Deal completed32.96%--
Clinical Solutions Group IncDeal completed31 Oct 202031 Oct 2020Deal completed66.46%--
Qh Research LtdDeal completed01 Oct 202001 Oct 2020Deal completed62.61%--
Data delayed at least 15 minutes, as of Sep 17 2021 21:10 BST.
Refinitiv, an LSEG business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
image